Keyphrases
18F-fluorodeoxyglucose (18F-FDG)
16%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
100%
Cancer Inpatients
16%
Cancer Staging
16%
Curative Esophagectomy
16%
Distant Metastasis
16%
Esophageal Cancer
100%
Esophageal Carcinoma
50%
Esophageal Tumor
16%
Esophagectomy
16%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
33%
Fluorodeoxyglucose Uptake
16%
Metastatic Disease
33%
Newly Diagnosed
16%
Nodal Disease
16%
Pathological Findings
16%
Positron Emission Tomography
100%
Primary Lung Carcinoma
16%
Regional Metastasis
16%
Surgical Procedures
16%
Tissue Sampling
50%
Unnecessary Surgery
16%
Unresectable Tumor
16%
Upper Abdomen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
33%
Distant Metastasis
33%
Esophagus Cancer
100%
Esophagus Carcinoma
100%
Esophagus Tumor
33%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
100%
Lung Carcinoma
33%
Malignant Neoplasm
33%
Metastasis
66%
Neoplasm
33%
Regional Metastasis
33%
Medicine and Dentistry
Disease
11%
Distant Metastasis
11%
Esophageal Cancer
100%
Esophagectomy
22%
Esophagus Carcinoma
33%
Esophagus Tumor
11%
Fluorodeoxyglucose
33%
Fluorodeoxyglucose F 18
100%
Health Care Cost
11%
Lung Carcinoma
11%
Malignant Neoplasm
11%
Metastatic Carcinoma
22%
Neoplasm
11%
Positron Emission Tomography
100%
Regional Metastasis
11%
Surgical Technique
11%
Tissue Sampling
33%